GLP-1 Fall Risk After 65: Mixed Evidence on Muscle Loss and Fractures
A 2026 records study finds fewer falls on semaglutide or tirzepatide in older adults with diabetes, while Wegovy's label flags more hip and pelvic fractures in patients 75…
Read article →